References
- 1. M. E. Czerwińska and M. F. Melzig, Cornus mas and Cornus Officinalis – Analogies and differences of two medicinal plants traditionally used, Front. Pharmacol. 9 (2018) Article ID 894 (28 pages); https://doi:10.3389/fphar.2018.0089410.3389/fphar.2018.00894612107830210335
- 2. H. K. Bhakta, C. H. Park, T. Yokozawa, B. S. Min, H. A. Jung and J. S. Choi, Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors, Arch. Pharm. Res. 39 (2016) 794–805; https://doi:10.1007/s12272-016-0745-510.1007/s12272-016-0745-527106028
- 3. E. J. Jeong, T. B. Kim, H. Yang, S. Y. Kang, S. Y. Kim, S. H. Sung and Y. C. Kim, Neuroprotective iridoid glycosides from Cornus officinalis fruits against glutamate-induced toxicity in HT22 hippocampal cells, Phytomedicine19 (2012) 317–321; https://doi:10.1016/j.phymed.2011.08.06810.1016/j.phymed.2011.08.06821982433
- 4. C. H. Park, J. S. Noh, J. H. Kim, T. Tanaka, Q. Zhao, K. Matsumoto, N. Shibahara and T. Yokozawa, Evaluation of morroniside, iridoid glycoside from Corni fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice, Biol. Pharm. Bull. 34 (2011) 1559–1565; https://doi.org/10.1248/bpb.34.155910.1248/bpb.34.155921963495
- 5. T. Yokozawa, N. Yamabe, H. Y. Kim, K. S. Kang, J. M. Hur, C. H. Park and T. Tanaka, Protective effects of morroniside isolated from Corni fructus against renal damage in streptozotocin-induced diabetic rats, Biol. Pharm. Bull. 31 (2008) 1422–1428; https://doi.org/10.1248/bpb.31.142210.1248/bpb.31.142218591786
- 6. C. H. Park, N. Yamabe, J. S. Noh, K. S. Kang, T. Tanaka and T. Yokozawa, The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice, Biol. Pharm. Bull. 32 (2009) 1734–1740; https://doi.org/10.1248/bpb.32.173410.1248/bpb.32.173419801836
- 7. Y. Takeda, N. Tanigawa, F. Sunghwa, M. Ninomiya, M. Hagiwara, K. Matsushita and M. Koketsu, Morroniside cinnamic acid conjugate as an anti-inflammatory agent, Bioorg. Med. Chem. Lett. 20 (2010) 4855–4857; https://doi.org/10.1016/j.bmcl.2010.06.09510.1016/j.bmcl.2010.06.09520621474
- 8. H. Oku, Y. Ogawa, E. Iwaoka and K. Ishiguro, Allergy-preventive effects of chlorogenic acid and iridoid derivatives from flower buds of Lonicera japonica, Biol. Pharm. Bull. 34 (2011) 1330–1333; https://doi.org/10.1248/bpb.34.133010.1248/bpb.34.133021804227
- 9. W. Wang, W. Huang, L. Li, H. Ai, F. Sun, C. Liu and Y. An, Morroniside prevents peroxide-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells, Cell. Mol. Neurobiol. 28 (2008) 293–305; https://doi.org/10.1007/s10571-007-9168-710.1007/s10571-007-9168-717647102
- 10. W. Wang, F. Sun, Y. An, H. Ai, L. Zhang, W. Huang and L. Li, Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity, Eur. J. Pharmacol. 613 (2009) 19–23; https://doi.org/10.1016/j.ejphar.2009.04.01310.1016/j.ejphar.2009.04.01319379729
- 11. W. Wang, J. Xu, L. Li, P. Wang, X. Ji, H. Ai, L. Zhang and L. Li, Neuroprotective effect of morroniside on focal cerebral ischemia in rats, Brain Res. Bull. 83 (2010) 196–201; https://doi.org/10.1016/j.brainresbull.2010.07.00310.1016/j.brainresbull.2010.07.00320637265
- 12. P. Mehta, R. Shah, S. Lohidasan and K. R. Mahadik, Pharmacokinetic profile of phytoconstituent(s) isolated from medicinal plants - A comprehensive review, J. Tradit. Complement. Med. 5 (2015) 207–227; https://doi:10.1016/j.jtcme.2014.11.04110.1016/j.jtcme.2014.11.041462436126587392
- 13. S. Xiong, J. L. Li, X. Q. Zhu, X. Y. Wang, G. Y. Lv and Z. Q. Zhang, Determination of morroniside concentration in rat plasma by high performance liquid chromatography-tandem mass spectrometry, China J. Chin. Mater. Med. 38 (2013) 3378–3381.
- 14. S. Xiong, J. L. Li, X. Q. Zhu, X. Y. Wang, G. Y. Lv and Z. Q. Zhang, Determination of morroniside concentration in beagle plasma and its pharmacokinetics by high performance liquid chromatography-tandem mass spectrometry, Chin. J. Chromatogr. 33 (2014) 290–293.10.3724/SP.J.1123.2013.1102724984470
- 15. S. Xiong, J. L. Li and Z. Q. Zhang, Excretion of morroniside in rat urine after single oral and intravenous administration, J. Chromatogr. Sci. 54 (2016) 912–917; https://doi.org/10.1093/chromsci/bmw01710.1093/chromsci/bmw01726896349
- 16. R. E. Buckingham, Indwelling catheters for direct recording of arterial blood pressure and intravenous injection of drugs in the conscious rat, J. Pharm. Pharmacol. 28 (1976) 459–461; https://doi.org/10.1111/j.2042-7158.1976.tb04660.x10.1111/j.2042-7158.1976.tb04660.x6764
- 17. P. Neerati, D. Ganji and S. K. Bedada, Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats, Eur. J. Pharm. Sci. 44 (2011) 27–31; https://doi:10.1016/j.ejps.2011.05.00510.1016/j.ejps.2011.05.00521640186
- 18. U. Fagerholm, M. Johansson and H. Lennernäs, Comparison between permeability coefficients in rat and human jejunum, Pharm. Res. 13 (1996) 1336–1342.10.1023/A:1016065715308
- 19. J. L. Brunet, M. Maresca, J. Fantini and L. P. Belzunces, Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model, Toxicol. Appl. Pharmacol. 194 (2004) 1–9; https://doi.org/10.1016/j.taap.2003.08.01810.1016/j.taap.2003.08.01814728974